Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Finlay

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|April 10, 2020
Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid ReceptorsDavid B Finlay, Kathleen J Sircombe, Mhairi Nimick, et al.
British Journal of Pharmacology|May 25, 2021
Exploring group size for statistical analysis of real-time signalling experimentsLiang Yang, Xiao Zhu, David B Finlay, et al.
ACS Sensors|September 30, 2025
Development of a Cell Membrane Conformational Cannabinoid CB<sub>1</sub> Receptor Biosensor for the Detection of Synthetic CannabinoidsMichelle Glass, Nahid Khalajiassadi, Shuli Chen, et al.
Pain|February 1, 1996
Transcutaneous electric nerve stimulation (TENS) during distension shoulder arthrography: a controlled trialBruno Morgan, Andrew R Jones, Kevin A Mulcahy, et al.
Pharmacology Research & Perspectives|November 29, 2023
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB<sub>2</sub> receptorMonica Patel, Natasha L Grimsey, Samuel D Banister, et al.
British Journal of Pharmacology|December 10, 2023
A quantitative pharmacology model for cannabinoid CB<sub>1</sub> receptor mediated by Gi/Gs protein competitionLiang Yang, David B Finlay, Hayley M Green, et al.
Biochemical Pharmacology|February 14, 2024
Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB<sub>1</sub> receptorBeth Ryalls, Monica Patel, Eric Sparkes, et al.
British Journal of Pharmacology|June 5, 2023
A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CBLiang Yang, Xiao Zhu, David B Finlay, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 16, 2024
Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical modelHayley M Green, Liang Yang, Xiao Zhu, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis StudiesHayley M Green, Daniel M J Fellner, David B Finlay, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|April 10, 2020
Terpenoids From Cannabis Do Not Mediate an Entourage Effect by Acting at Cannabinoid ReceptorsDavid B Finlay, Kathleen J Sircombe, Mhairi Nimick, et al.
British Journal of Pharmacology|May 25, 2021
Exploring group size for statistical analysis of real-time signalling experimentsLiang Yang, Xiao Zhu, David B Finlay, et al.
ACS Sensors|September 30, 2025
Development of a Cell Membrane Conformational Cannabinoid CB<sub>1</sub> Receptor Biosensor for the Detection of Synthetic CannabinoidsMichelle Glass, Nahid Khalajiassadi, Shuli Chen, et al.
Pain|February 1, 1996
Transcutaneous electric nerve stimulation (TENS) during distension shoulder arthrography: a controlled trialBruno Morgan, Andrew R Jones, Kevin A Mulcahy, et al.
Pharmacology Research & Perspectives|November 29, 2023
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB<sub>2</sub> receptorMonica Patel, Natasha L Grimsey, Samuel D Banister, et al.
British Journal of Pharmacology|December 10, 2023
A quantitative pharmacology model for cannabinoid CB<sub>1</sub> receptor mediated by Gi/Gs protein competitionLiang Yang, David B Finlay, Hayley M Green, et al.
Biochemical Pharmacology|February 14, 2024
Investigating selectivity and bias for G protein subtypes and β-arrestins by synthetic cannabinoid receptor agonists at the cannabinoid CB<sub>1</sub> receptorBeth Ryalls, Monica Patel, Eric Sparkes, et al.
British Journal of Pharmacology|June 5, 2023
A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid (CBLiang Yang, Xiao Zhu, David B Finlay, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|January 16, 2024
Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical modelHayley M Green, Liang Yang, Xiao Zhu, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis StudiesHayley M Green, Daniel M J Fellner, David B Finlay, et al.
Pageof 4